Aeon Biopharma Inc (AEON)

$6.21

-0.09

(-1.43%)

Market is closed - opens 7 PM, 21 Sep 2023

Insights on Aeon Biopharma Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 91.9% return, outperforming this stock by 127.9%

Performance

  • $6.07
    $6.58
    $6.21
    downward going graph

    2.25%

    Downside

    Day's Volatility :7.75%

    Upside

    5.62%

    downward going graph
  • $3.37
    $14.68
    $6.21
    downward going graph

    45.73%

    Downside

    52 Weeks Volatility :77.04%

    Upside

    57.7%

    downward going graph

Returns

PeriodAeon Biopharma IncIndex (Russel 2000)
3 Months
-23.36%
0.0%
6 Months
-38.05%
-0.5%
1 Year
-35.98%
0.4%
3 Years
-34.72%
19.1%

Highlights

Market Capitalization
196.2M
Book Value
- $2.19
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.23
Wall Street Target Price
18.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-51.9M
Diluted Eps TTM
-2.23
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.17
EPS Estimate Next Year
-1.54
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 189.86%

Current $6.21
Target $18.00

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aeon Biopharma Inc
Aeon Biopharma Inc
50.36%
-38.05%
-35.98%
-34.72%
-34.72%
Moderna, Inc.
Moderna, Inc.
-3.91%
-29.82%
-15.12%
54.11%
473.87%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.9%
10.13%
22.22%
50.58%
114.4%
Novo Nordisk A/s
Novo Nordisk A/s
2.45%
29.29%
91.93%
176.03%
299.56%
Seagen, Inc.
Seagen, Inc.
7.77%
4.2%
47.16%
16.48%
167.89%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
2.14%
18.37%
27.77%
35.7%
98.94%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aeon Biopharma Inc
Aeon Biopharma Inc
NA
NA
NA
-1.17
0.0
0.0
0.0
-2.19
Moderna, Inc.
Moderna, Inc.
35.66
35.66
0.0
-3.66
0.07
0.01
0.0
44.49
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
22.39
22.39
9.01
41.82
0.19
0.1
0.0
225.94
Novo Nordisk A/s
Novo Nordisk A/s
43.6
43.6
2.03
3.3
0.82
0.22
0.01
2.52
Seagen, Inc.
Seagen, Inc.
NA
NA
18.53
-3.47
-0.26
-0.13
0.0
13.96
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
27.75
27.75
0.41
14.71
0.25
0.16
0.0
60.01
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aeon Biopharma Inc
Aeon Biopharma Inc
NA
$196.2M
-34.72%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$39.6B
473.87%
35.66
11.33%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$90.8B
114.4%
22.39
33.93%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$834.9B
299.56%
43.6
33.4%
Seagen, Inc.
Seagen, Inc.
Hold
$38.9B
167.89%
NA
-33.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$92.5B
98.94%
27.75
35.4%

Company Information

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.

Organization
Aeon Biopharma Inc
Employees
9
CEO
Industry
Miscellaneous

FAQs